ctrl K

Bicara Therapeutics Inc. ... (BCAX)

NASDAQ: BCAX · Real-Time Price · USD

14.69

-0.02 (-0.14%)

At close: May 02, 2025, 3:59 PM

14.50

-1.26%

After-hours: May 02, 2025, 04:05 PM EDT

Bicara Therapeutics Common Stock Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Revenue	n/a	n/a	n/a
Cost of Revenue	n/a	n/a	n/a
Gross Profit	n/a	n/a	n/a
Operating Income	-82.39M	-39.89M	-37.66M
Interest Income	14.58M	1.31M	4K
Pretax Income	-67.81M	-51.98M	-37.84M
Net Income	-68M	-51.98M	-37.84M
Selling & General & Admin	18.77M	9.27M	6.34M
Research & Development	8.22M	30.62M	31.31M
Other Expenses	55.4M	n/a	n/a
Operating Expenses	82.39M	39.89M	37.66M
Interest Expense	n/a	n/a	112K
Selling & Marketing Expenses	n/a	n/a	n/a
Cost & Expenses	n/a	39.89M	37.66M
Income Tax Expense	187K	5K	1K
Shares Outstanding (Basic)	168.06M	51.76M	51.76M
Shares Outstanding (Diluted)	168.06M	51.76M	51.76M
EPS (Basic)	-0.4	-1	-0.73
EPS (Diluted)	-0.4	-1	-0.73
EBITDA	-67.75M	-51.96M	-37.72M
EBIT	-67.81M	-51.98M	-37.73M
Depreciation & Amortization	56K	19K	10K